supported by Zhejiang Major R&D programs(2021C03042);Key R&D Program of Zhejiang Respiratory Disease(2023C03069);Zhejiang Provincial Clinical Research Center for Respiratory Disease(2022E50005).
Osimertinib,a third-generation epidermal growth factor receptor tyrosine kinase inhibitor(EGFR-TKI),has demonstrated significant clinical benefits in the treatment of EGFR-mutated non-small cell lung cancer(NSCLC).How...
supported by the National Natural Science Foundation of China (No.81572447,31871427,32260173);Zhongnan Hospital-Taikang Medical School (School of Basic Medical Sciences)of Wuhan University Joint Foundation (No.JCZN2022010);supported by the intramural program of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD),National Institutes of Health (NIH),USA.
Sex-determining region Y-box protein 3(SOX3)is a member of the SoxB1 transcription factors subfamily including SOX1 and sox2,first identified based on homology to the high mobility box.1 The oncogenic potential of the...